OPTN/SRTR 2023 Annual Data Report: Pancreas.

The overall number of pancreas transplants in the United States remained relatively unchanged in 2023 at 915 transplants, compared with 918 transplants in 2022. The number of pancreas-after-kidney transplants continued to decline and reached the lowest level in the past decade: 36 transplants in 2023. The proportion of pancreas recipients with type 2 diabetes increased to 25.4% in 2023 from 22.5% in 2022, comparable to the proportion of candidates with type 2 diabetes on the waiting list increasing to 25.2% in 2023 compared with 23.4% in 2022. The number of adult additions to the pancreas waiting list increased in 2023 to 1,876 compared with 1,736 in 2022. The proportion of candidates on the waiting list who are older, obese, or have type 2 diabetes has been increasing. The number of pancreas donors decreased in 2023 compared with 2022; however, the nonuse rate also decreased during the same period. The distribution of volume across transplant centers was relatively unchanged in 2023, with only 5% of centers performing more than 30 transplants a year. Outcomes of pancreas transplants were relatively stable from 2020 to 2022, with 1-year pancreas graft survival rates in adults of 90.8% in simultaneous pancreas-kidney transplant, 87.5% in pancreas transplant alone, and 84.4% in pancreas-after-kidney transplant for transplants performed in 2022. Kidney 1-year graft survival in simultaneous pancreas-kidney transplant was excellent at 96.2% for transplants in 2022.